Company / Interest Expense
TREACE MEDICAL CONCEPTS, INC. Interest Expense History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$5.2M
FY2025
5-year range
$841.0K / $5.2M
FY2021-FY2025
Trend
+17.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense has increased for 4 consecutive years, from $841,000 in FY2021 to $5M in FY2025.
Based on SEC 10-K filings.
$5M in FY2025 with a 3-year CAGR of +23.0%.
Increased from $4M to $5M over the past 2 years.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +23.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- TREACE MEDICAL CONCEPTS, INC.'s interest expense has grown for 4 consecutive years.
- 3-year CAGR of +23.0%, indicating consistent growth.
- In FY2025, interest expense increased 17.5% year-over-year.
- Lowest interest expense in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.2M | +17.5% |
| FY2024 | $4.4M | +8.3% |
| FY2023 | $4.1M | +46.2% |
| FY2022 | $2.8M | +230.2% |
| FY2021 | $841.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026